Neil Kumar

2019 - BridgeBio Pharma

In 2019, Neil Kumar earned a total compensation of $26.3M as Chief Executive Officer at BridgeBio Pharma, a 5,752% increase compared to previous year.

Compensation breakdown

Bonus$360,000
Option Awards$11,573,049
Salary$502,765
Stock Awards$13,863,445
Other$34,804
Total$26,334,063

Kumar received $13.9M in stock awards, accounting for 53% of the total pay in 2019.

Kumar also received $360K in bonus, $11.6M in option awards, $502.8K in salary and $34.8K in other compensation.

Rankings

In 2019, Neil Kumar's compensation ranked 70th out of 13,971 executives tracked by ExecPay. In other words, Kumar earned more than 99.5% of executives.

ClassificationRankingPercentile
All
70
out of 13,971
100th
Division
Manufacturing
21
out of 5,692
100th
Major group
Chemicals And Allied Products
5
out of 2,189
100th
Industry group
Drugs
5
out of 1,875
100th
Industry
Pharmaceutical Preparations
4
out of 1,387
100th
Source: SEC filing on April 22, 2020.

Kumar's colleagues

We found two more compensation records of executives who worked with Neil Kumar at BridgeBio Pharma in 2019.

2019

Brian Stolz

BridgeBio Pharma

Chief Operating Officer

2019

Charles Homcy

BridgeBio Pharma

Chairman

News

You may also like